Citius Pharmaceuticals (CTXR) Misses Q2 EPS by 11c

Citius Pharmaceuticals (NASDAQ: CTXR) reported Q2 EPS of ($0.11).

For earnings history and earnings-related data on Citius Pharmaceuticals (CTXR) click here.

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• Etsy upgraded to buy at BofA on durable growth, buyback potential